Source: Annual Congress 2002 - Prevalence and costs of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. M. Siafakas, (On Behalf of COPD Group) (Heraklion, Greece). Prevalence of chronic obstructive pulmonary disease (COPD) in Greece. Eur Respir J 2002; 20: Suppl. 38, 814

Member's Comments

No comment yet.

Related content which might interest you: Awareness of chronic obstructive pulmonary disease (COPD) in Portugal Source: Eur Respir J 2007; 30: Suppl. 51, 126s Year: 2007 Prevalence of chronic obstructive pulmonary disease (COPD) in a general population in Norway Source: Annual Congress 2012 - COPD epidemiology Year: 2012 Prevalence of chronic obstructive pulmonary disease (COPD) in primary care Source: Annual Congress 2008 - Issues in the management of COPD in the community Year: 2008 Functional illiteracy amongst those with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 57s Year: 2005 Correlates of osteoporosis in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 The state of patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2007; 30: Suppl. 51, 547s Year: 2007 Periodontitis and chronic obstructive pulmonary disease Source: Annual Congress 2006 - COPD and inflammation Year: 2006 Awareness of chronic obstructive pulmonary disease (COPD) in Portugal general practicioners Source: Eur Respir J 2007; 30: Suppl. 51, 129s Year: 2007 Prevalence of bronchiectasis in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 60s Year: 2006 Chronic obstructive pulmonary disease (COPD) – patient‘s perspective Source: Eur Respir J 2007; 30: Suppl. 51, 168s Year: 2007 Economic burdens of patients with chronic obstructive pulmonary disease (COPD) in Japan Source: Eur Respir J 2006; 28: Suppl. 50, 108s Year: 2006 Vaccination efficacy in workers with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 107s Year: 2006 Etiologies of exacerbations of the chronic obstructive pulmonary disease in Tunisia Source: Annual Congress 2013 –Lung infections: a clinical point of view Year: 2013 Impact of comorbidities on chronic obstructive pulmonary disease (COPD) exacerbations in Singapore Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Exacerbations in chronic obstructive pulmonary disease (COPD) in Ontario, Canada Source: Virtual Congress 2021 – Exacerbations of chronic respiratory diseases, including SARS-CoV-2 Year: 2021 Accelerated ageing and chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2003 - Cigarette smoke: how it does its dirty work Year: 2003 The evaluation of a helpline for chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2004 - Smoking and cessation in respiratory disease Year: 2004 The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Prevalence of metabolic syndrome in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Bronchiectasis impact outcomes in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008